Grants for Public housing authorities - Food and Nutrition

This funding opportunity supports clinicians with doctoral degrees who are seeking to develop their research careers in biomedical and behavioral fields, enabling them to become independent investigators while engaging in research within existing clinical trials.

This grant provides funding and support for early-career researchers in the biomedical, behavioral, or clinical sciences to gain the skills and experience needed to become independent investigators, without leading their own clinical trials.

This funding opportunity supports nonprofit organizations in Maine, particularly in Brunswick, Southport, and Boothbay Harbor, focusing on projects that aid those in need, promote animal welfare, provide healthcare for underserved populations, and support public broadcasting.

This funding opportunity provides up to $10,000 to schools, businesses, and nonprofits in Ramsey and Washington counties, Minnesota, to enhance recycling and organic waste collection efforts over an 18-month period.

This funding opportunity provides multi-year financial support to nonprofit and public sector organizations in Minnesota and northwestern Wisconsin that are working on community-driven solutions to address systemic inequities and promote opportunity, resilience, and belonging for historically marginalized populations.

This grant provides funding to support outstanding postdoctoral researchers in transitioning to independent faculty roles while conducting clinical trials and developing their own research programs.

This funding opportunity supports full-time research software engineers at academic institutions who are working on NIH-funded projects, enabling them to develop and maintain essential software tools for biomedical and health research.

This funding opportunity supports researchers and institutions in developing innovative, non-addictive pain treatments through early-stage drug discovery and assay development, with a focus on alternatives to opioid therapies.

This funding opportunity supports researchers investigating the connections between HIV/AIDS and conditions related to diabetes, digestive diseases, kidney issues, and obesity, aiming to improve understanding and treatment of these interconnected health challenges.

This program provides funding to early-career researchers who have received specific NIDDK K awards, enabling them to conduct small-scale research projects that will help them transition to independent investigator roles.

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

This funding opportunity is designed to establish a center that will coordinate and advance research on whole person health by integrating diverse biomedical knowledge and fostering collaboration among researchers.

The "Type 1 Diabetes TrialNet Clinical Network Hub" grant aims to support the coordination unit for clinical trials focused on preventing and intervening early in type 1 diabetes, by improving communication, outreach, and developing new strategies for better screening, recruitment, and retention of participants.

This grant provides funding for interdisciplinary research teams to explore the neural and behavioral aspects of benign urological conditions, aiming to improve understanding and treatment of these diseases.

The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA.

This funding opportunity provides financial support to researchers with active NIH grants to address unexpected costs and enhance their projects without changing the original research scope.

This funding opportunity supports research that explores the effects of aging on individuals living with HIV, focusing on improving health outcomes and management strategies for this population.

This funding opportunity supports multi-site clinical trials aimed at testing high-risk medical interventions for diseases related to diabetes, digestive disorders, and kidney health, targeting a wide range of eligible organizations including universities, nonprofits, and businesses.

This funding opportunity supports U.S.-based organizations in evaluating the impact of upcoming public policies and programs that aim to improve health behaviors and reduce chronic disease risk factors through behavioral changes.

This funding opportunity supports U.S.-based researchers and organizations in developing non-addictive pain relief therapies to combat the opioid crisis, with a focus on advancing preclinical candidates toward clinical trials.